PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION
Product details
Registration number: SIN08899P
Classification: Prescription Only
Active ingredients:
- COPPER CHLORIDE DIHYDRATE
- MANGANESE CHLORIDE TETRAHYDRATE
- POTASSIUM IODIDE
- SODIUM FLUORIDE
- SODIUM SELENITE ANHYDROUS
- ZINC CHLORIDE
Strength:
- 53.7 mcg/ml
- 3.6 mcg/ml
- 1.31 mcg/ml
- 126 mcg/ml
- 4.38 mcg/ml
- 521 mcg/ml
Dosage form: INJECTION
Route: INTRAVENOUS
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
ATC code: A12CX
HSA approval date: 4 September 1996
Manufacturer(s): HP HALDEN PHARMA AS
Manufacturing country/countries: NORWAY
What are the HSA registration number and classification for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN08899P
Classification: Prescription Only
What active ingredients and strength are recorded for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- COPPER CHLORIDE DIHYDRATE
- MANGANESE CHLORIDE TETRAHYDRATE
- POTASSIUM IODIDE
- SODIUM FLUORIDE
- SODIUM SELENITE ANHYDROUS
- ZINC CHLORIDE
Strength:
- 53.7 mcg/ml
- 3.6 mcg/ml
- 1.31 mcg/ml
- 126 mcg/ml
- 4.38 mcg/ml
- 521 mcg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS
Who is the recorded registrant for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?
According to the HSA dataset updated 7 August 2026:
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): HP HALDEN PHARMA AS
Manufacturing country/countries: NORWAY
Where can I look up PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN08899P or the exact product name PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION. The general register link does not preselect this product.
What are the source dates for this PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PEDITRACE CONCENTRATE FOR PARENTERAL INFUSION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN08899P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)